Document dYmvEpmDZQyXb25Vw1jzDYj9B

DownloadRandom document
off AR 286 -- 1305" March 14, 2003 Mr. Stephen L. Johnson `Assistant Administrator for USPrEevnevnitrioonnm,enPetsatlicPirdoetsecatnidonToAxgiecncSuyb(st7a1n0c1eMs) 1200Pennsylvania AvenueNW. Washington, DC 20460 Re: Letter of Intent for the Telomer Research Program Dear Mr. Johnson: g =ER on al == 55&9 TM = `compris`eThtehepamratjieosrttoetlhoimselretptrero,duacsemrse,mbheavresporfetphaereTdelthoimseLretRteesreoafrcIhntPenrtog(rLOaIm)(tToRaPd)d'rewshsich qasuseosctiiaotnisonroaifspederbfylutohreoUocStaEnnoviicraocnimden(tPaFlOPAr)otweictthiotnelAogmeenrc-bya(seEdPAp)rodaubcotust. thTehpeospsuirbploese of this sleutmtemrairs ytooaff(fii)rtmhoeuarctcioomnmsitthemepnarttiteosraerseppounrdsiunigngtoitnh2e0c0o3n,ceirfnsadodfittihoenaElPpAroadnudcttosptreowvairddeshaip `measures EPA, and that (iv) twhoerTkRcPonmdeucmtbeedrsto wdialtle.implement, (ii) information that the TRP will provide the they con`tTrhiebuTtRePtoissiegvnailfuiactanitnghtuemlaonmeorrpernovdiurcotnsmseonltdalinetxhpeosUunrietetdoSPtFatOeAs.toOduerteervmailnueatwihoenthhaesr six key components. 1. Analysis of products and articles 2. Analysisof "aged" products and "in use" articles 3. 4. Characterization Characterization of potential of potential release ofPFOA release of PFOA from from telomer-based product manufacture telomer-treated article manufacture 5. 6. AEnvaallyusaitsioonfopfostshiebulletibmiaotdeegfraatdeaatnidondiosfptoseallomreoru-tbeassfeodrptoellyommeerr-itcrepartoedducatrtsicles in the United States EPA has expressed a concern to our industry about reports of low but widespread levels of PFOA in human blood. We recognize tha, although there is no evidence ofa health effect at the levels found, the presence of PFOA in blood is a concern for EPA. Telomers are not made fharvoem aPrFisOeAn,abnoourtisthPeFpOotAenatidadledordutreilnogmetrhse m10anturfaancstfuorrem otor PusFeOoAf tuenldoemrervaprriooduusctcso.ndiQtuioensst.ionWse bpoetleinetviealthceonpovteernstiioaln fwoorusludchbetrsmaanlslf,oramnadtitohneiosvesrmaallll,coanntyriPbFutOiAonloefvetlesltohmaetrmparyodruecstuslttforhoummtahnis exposure to PFOA consequently would be negligible. However, the TRP members commit to *NTehmeoucrosm&panCioemsppaanryi.ipating in theTRP include Asahi Glass, Clariant GmbH, Daikin Industries and E.. duPontde 1 Mr. Stephen L. Johnson March 14, 2003 Page2 verifying that these this responsibility. assumptions are true and have set forth below a program of research to meet repellenFtsluaonrdotbealrorimeerrssfaorrecuasrpeedtsi,n calontuhminbge,ruopfhoslpsetceirayl,izaenddppraopdeurc;tsmoilncdlurdeilnega:seswaftorerplaanstdicoiland rfluobobrepromlioslhd,inign;ksaaqnudeoaursafniglemoffosrimmiinlgarfaopapmlsic(atAioFnsF. fTirheefrieghitsionnglaygeonntse);TRanPdmweemltbienrg cagoemnptasnfyor (DuPont) that manufactures both the basic telomer chemicals and end-use products in the United States. One additional TRP member (Daikin) is a manufacturer who imports the basic telomer chemicals and processes them into end-use products in the United States. The other TRP cStoamtepsa.niAepspr(oAsxaihmiatGellayss9a0n%d oCflatrhieanvto)laurmeeiompfotretlionmgerenpdr-oudsuecttselgoomeesrtporiondduucsttsritaol tuhseerUsn,iwthedo apply them to carpets, textiles and paper at the mill sites, coat them on various surfaces (.g., `molding machines), or mix them into polishes, inks and other products. As supplied to those industrial users, telomer-based products may contain PFOA as an impurity in trace amounts. Given the known worldwide production of telomers, the levels of PFOA that would be placed in commerce per year, based on this understanding, is expected to be relatively small. We are not sure how that amount of PFOA is formed, but this information may suggest that there is some potential for telomers to transform to PFOA. We are now trying to determine whether there are relevant routes by which telomers may, in fact, transform io PFOA and to what degree these transformations take place. An important element of this LOI is our evaluation of this question. Investigating the amount of PFOA from telomer products is made more challenging by direct inputs of PFOA from other sources into the environment and by environmental loadings from legacies attributable to widespread useof discontinued surfactants and oil- and waterrepellent chemistries. In all of the projects described in the commitment section of this LOI, the TRP members airnetecnodndtoucdteilinvgerredlaattiavtehlaytswhiolrlt-mteeertm EscPrAe'esnignugidaenlailnyessesf,orweinifnotremnadtitoonmqeueatliatyp.p"roEpvreiantwehEePreA we standards. Our commitment to data quality will not compromise our efforts to supply the EPA `with information in an expeditious manner. `The TRPiscommitted to conductinag proactive program to develop additional data on environmental fate of our products, better characterize routes of exposure, strengthen product stewardship and risk communication practices, and take additional measures to reduce or prevent exposure wherever new data suggest that such changes are needed. BthePOAffhicaeosfsuMeadnaIgnfeomremnattinondQuBuadlgietty.GuiTdRePlinaelss,o iwinlclocnofnosrimdearncEePwAitOhrhdeerD#a5t3a60Q.u1alit82y A(cQtuanlidtygSuiydsatnecmefiossufeudrtbhyer suidance on how to document QA/QC measures. RX Mr. Stephen L. Johnson March 14, 2003 Page 3 TRP Voluntary Commitment below r`eTlhaetemdetmobteerlsomoefrtphreodTuRcPtsa.rTeRwPorwkiillngprtoovgiedtehepretroiocdoimcpblreiteefitnhges atsosEePssAmesnttasffdteoscribed summarize recent results occur at least monthly in from 2003. these telomer-related In addition, the TRP studies. These briefings are expected will provide new documents, other to `materials and final study reports to EPA as soon as they become available. 1. ProductandArticle Analysis PFOA i`nThteheTmRaPjohrasencdo-nutsreactteeldowmietrhparnodouucttssidien creosmemaercrhcleabaonrdataorrtyictleosatnraelaytzeed fwoirththtehopsreesence of products. TRP will provide EPA with adescription of the scope and rationale for analysis of TPRFPOAanianlytteilcoalmeerx-pbearstesdhpaovleydmeevreilcoppreoddutchtesapapnrdoptreilaotmeers-atmrepaltiendgaarntidclaensadlyusriisngplMaanrscahs 2we0l0l3.as a"nSaalmytpilcianlgsGtauniddaarndcsef"orwethreewporrokv.idDerdatfot tphleanEsPfAorotnheFe"bPrruoadruyct1a4,nd20A0r3ticfloer Arneavliyeswiasn"dsctuodmymeanndt. The screening study will begin in March 2003; the final report is expected by June / July 2003. `The results will be provided to EPA as soon as they are available. primary`Tphriosdauncatlsystihastwiolulr amdedmrebsesrsthrmeaerkmeatjofrorutsheecsaetaegpoprliiecsa:tiocnasrpaertes,potelxytmielerssa(nadpppraopexri.matTehley 8th5e%reosfpewchtaitvetTheRTPRmPemmebmebrecrosmpmaanniufeascmtaunruefaancdtusrelel)a.s aTchteuaplriotdeumcstsoftocboemmteesrtceed.arWehtihloeseththearte are many potential telomer polymeric products, a relatively small number represent the primary cporomdpurcethecnlassisvees iinnitcioalmmpiecrtcuree (o1f2epxrpoodsucutrse).potAenstiaalrebsuyltf,otchuesiTnRgPonwitlhlesperomvaijdoerEePndA-uwsiethpoalymers atenxdtitleh,eacnodrrpeasppeorndsiubnsgtarrattiecsletsreoaftecdomumndeerrcer.eprTehseenttraetaitveedmairltliccloensdtiotiboenstewsittedh atrhee ascutbujaelctcatrepleotm,erbased polymeric products. `The chemical identities of these particular polymers, volumes, and their relative market sAhgaerne,cyarweiCtohnfsipedceinftiicaslaBbuosuitneesaschInpfoolrymmaetriotno (bCeBIte)s.teTd,hesuTchRPasmietsmbsterrucstuirnet,eCndAtSo pnruomvbiedre,the chemical name, 2002 use and volume in commerce, through company.-specific submissions. This information will be supplied to the EPA by March 24, 2003. TRP companies will also parnodvivdoeluEmPeAs i(nuncdoemrmCeBrIc)esopfecailflioctshseurcthelaosmsetrrupcrtoudreusc,tsCuAsSednuinmbtehresU,nictheedmiSctaaltensa(miensc,lu2d0i0ng2 nuosne-s polymeric products) by May 2003. 2. Analysisof "Aged" Products and "In Use" Articles `The TRP members will examine transformation of end-use telomer products for potential PFOA generation that might occur through storage of the product over time or through normal "uisneuosfet"reaantaeldysaretsicolfest.he`sTpRePciwfiilclpdreovdeulcotpsaanpdlatnrebayteAdprairtlic2l0e0s3tfhoart caroendtuhcetsiunbgjePctFOofAth"eagTiRnPg"-and sponsored work in Item I above. For these analyses, "aged" means thelikely conditions our 3 Mr. Stephen L. Johnson March 14, 2003 Page 4 aprrtoidculcestswiwlilllseseeeunudnedrernonromramlaldissttorriabguetiaonndandidstursieb.utSiotnu.dy"Ipnro-tuosceo"lms,eaannaslytthiecaclonmdeitthioodnss tarnedated raepfplreocptrsiaatneetwesatrceoanodiftrieosnesarwcihllfboer tdheevTelRoPp.edRefosrultthsisowfotrhiksdsutruidnygatrheeesxepceocntdedqutaorbteerc2om0p0l3eatsetihnis tdheetetrhmiridniqnugarwtheert2h0e0r3.orTnhoet PstFuOdyAprreolteoacsoelssawriilsle bferodmesrieganle-dwotroldacchoinedvietieoxnpse,dciotnisoiussternetsuwltisthwhile EPA' quality guidelines / procedures. 3. Characterizing Potential ReleaseofPFOA from Telomer-Based Product Manufacture chemistrIny Feembprluoayreyd2i0n03t,eltohmeeTrRmPanpurfeascetnutreidngtoaEnPd Apraocgeesnseirnagl odpeesrcartiipotniso.nAosf tahefoplrloocwesusp, the oTfRMParwiclhl p2r0e0p3a.reHaonwdevseurb,mictacahgTenRePralmiezmedbeprroccoesmspascnhyemuasetsicuanniqdudeespcrroicpetsisoenstiontihtes EPA by end `TmRaPnufmaecmtubreirngtoepleormaetriopnrso.cesEsaicnhg amnedmbmaenrufcaocmtpuarninygwfialclilpirtoyvbiydeMathrechloc2a4t,i2on00o3f eaancdhmUeSe-tbased stheepaUrnaitetleyd wSittathest.heEAagcehncmyemtobeexrpclaoimnpiatsnyovewirlalllalisnodisvhiadruealinpfroorcmeasst,iofnocaubsoiuntgpootnenittsiaolperrealteiaosnesofin PwiFllOdAoefrineexpacotsiuorneplpaonisntbsyftrhoemeintds UoSf-Mbaayse2d0p0r3octeosisnevsesbtyigtahteeetnhde opoftAepnrtiiall2f0o0r3P.FTOhAerceolemapsaenaineds eixnpdiovsiudruea.llTyhteo smcehmebduelresothfesTeRbPrieafriengasv.ailable to begin discussions immediately and will call fully intIengardadtiedtiUonSttoetlhoemTerRPp-rsodpuocnesro,rmeadksetsudtiheescdoesmcmriitbmeednatbsovsee,t DfourPtohnitn,Awphpiecnhdiisxth1 e only 4. Characterizing Potential Release ofPFOAfrom Telomer-TreatedArticle Manufacture `The TRP members will examine the potential for PFOA releases or occupational eoxnpaorstuircleess aotfUcSomfmaceirlicteieseftfhiactiemnatlnyu,fwacetbuerleiteevleotmheirs-tirnefaotremdatairtoincliess.besItn oarsdseermbtloecdontdhurcotugrhesa.earch arretliecalseeteyspteisma--ctaermpoetd,elteaxntailleyssiasnddirpeactpeed~ratthmaatnaurfeacatdudrreesosfedthientohtrheeerpTriRmParwyortkeslotmreera-mtsr.eaTtehde TanRaPlyswiisllwceonwdilulctaattesmtputdytotoiddeentteirfymipnoetetnhteiaelstriemlaetasees poofinptost,enetxiaplosruerleeapsaetohfwaPyFsO,Aa.ndInultthiimsate etnrevaitreodnamretnictlaelmcaonmupfaarcttumreinntgsp(raoirc,eslsaends,. wIattiesro)ufrorexppoetcetntaitailonPtFhOatAtheimsiasnsailoynssisfrwiolmlbteelcoomemrp-lete by Ju/nJuely than August / 2003. The September final 2003. reports from this analysis will be provided to the EPA no later demonst`rWahtielethtehererqeulieraesde seastmipmlaitnegsatnuddieasnaalryetiucnadlemrewtahyo,dtshefoTrRPPFOwiAllipnrtohceeemidlltosdiemvuelaltoipoansnd described below. We expect this work to be completed in the third quarter 2003. The release ereslteiamsaeteofanPaFlyOsiAs fwrilolmbteeluosmeedr-ttorefiartsetddearstiigcnleamnadnuthfeanctcuornidnugctopmeirlaltisoinmsu.laAticoonnstorfactthelapbootreanttoirayl. capable of simulating the actual mill environment under defined and known conditions will be used (0 verify the data generated in the above release estimate study. The mill simulations are I's Mr. Stephen L. Johnson March 14, 2003 Page 5 ewixlplecbteeudsteodbteogeisntdiumraitengthtehepottheinrtdiqaulaorctcerup2a0t0i3o.nalThaendreesnuvltisrofnrmoemnttahel aenxaployssuisreantodPsiFmOulAatfiroonms athnedsApsetciicflieedAntaellyosmiesr-itnreIatteemd 1arotfictlheimsalnetutfear,ctisureixnpgecptreodcetsosepsr.ovTihdiesawmoorrke, caloomnpgrewhietnhstihveePpriocdtuucrte to aid in the understanding of the potential from telomer-treated article manufacturing occupational processes. and environmental exposure to PFOA S. Biodegradation Analysis PFOA `The TRP will gather information about whether and how telomers through biodegradation under environmentally relevant conditions. might degrade The TRP will to conduct further biodegradation studies; see "Continuationof TRP Research Activities" for method development studies with the 8-2 Telomer Alcohol to test for the potential generation of PFOA. `uTsheedseinsttuhdeiPesrowdiulcltfoalnldowAratpipclreopArniaaltyesOisE(CIDtemp)r.otoTcholessefosrctrheeentienlgomteesrt-sbwaisleldpproolvyimdeeruiscefpurlodduacttas on the potential for biodegradation to PFOA from major end-use telomer-based polymeric products. TRP will develop the study approach, protocols and rationale, and submit these to the US EPA by April 2003 for review and comment. Then in the second/third quarter 2003, we will cstounddyucatbotvhee.biIonditeigarlardeastuilotsn aarnealeyxspiescotfedthbeetgeilnonmienrg-binasJeudlyp2o0l0y3m.eriFcinparlordeupcotrstssewlielcltbede fsourbmtihetted 10 EPA as 500n as they become available. 6. Analysis of Incineration incinera`tTihoenTvRePrshuasslabnedfgiulnl)toofctohmepitleeloimnefro-rbmaasteidonpoolnymtehreiucltpirmoadtuectfsataenadndardtiicslpeossatrleraotuedteisn the United States. The results of his study will be provided to EPA by July 2003. Concurrently, `TRP will examine information available on types of incineration tests that may be applicable and will provide this information to EPA by the end of the second quarter 2003, Related Activities Information Exchange Over the last several years the TRP member companies have prepared and collected numerous studies and reports about telomers. Many of these documents are drawn from the public literature, but some represent unpublished reports. In addition, we have unpublished reports that have been produced for the TRP. Both the published and unpublished documents include summaries `pharmacokinetics, from TRP and non-TRP studies on and environmental fate and effects. physical-chemical properties, toxicology. To expedite the flow of information, TRP will provide the EPA with a listing of the documents in the TRP database by March 24, 2003. Copies of the documents will follow as soon as they canbe compiled but no later than April 15, 2003. If EPA requests companyspecific information, the company will supply the information to EPA with appropriate: confidential business information claims, as provided for under EPA regulations. Mr. Stephen L. Johnson March 14, 2003 Page 6 EPA asIsnoaodndiatsiotnh,eyTbRePcowimlel pavraoivliadbelen.eIwnddiovciudmueanltcso,moptahneiremsatweilrliaallssoansdubfminiatldsotcuudmyernetpso,rts to information, and final study reports to EPA related to their own studies on products sold in the UbrSiemfianrgksettoaEsPsAoosntaafsftthoesyubmemcaormiezeavraeicleanblter.esuIlntsadfdritoimont,heTsRe Ptewliolmlerc-ornetliantueed tsotupdrioevs.idTehpeesreiodic briefings are expected to occur at least monthly in 2003. TRP will also provide EPA advance noticeof upcoming studies and reports. Product Stewardshipfor Customers `The TRP members are committed to the continued safe manufacture and use of telomerbased products. The TRP acknowledges that it is equally important to continue to establish and support responsible occupational health and environmental practices in the se of telomer products. TRP member companies have in place product stewardship practices with their customers. related to the application, use and occupational exposure to telomer-based products, and have ach adopted workplace health and safety practices to minimize occupational exposure. These activities are essential parts of long-standing product stewardship programs and are ongoing. Further efforts on occupational product stewardship programs will focus on technical support and assistance to telomer-based product users (customers) to assist them in keeping their occupational safety and health programs current. Accordingly, the TRP members' product stewardship role is to provide the necessary information, assist in the understandingof the. information, and provide support to customers using telomer-based products. `The TRP has no single unified product stewardship program. As a result, the TRP member companies plan to have additional product stewardship programs in place by July 2003. `These programs willbedeveloped with reference to the Responsible Care guidelines outlined in SOCMA Management Practices/ Product Stewardship Code. Each member company will provide documented evidence for their respective programs to EPA by July 2003. In addition, the TRP believes the development and distributionof a "Safe Handling and Use" handbook would be a valuable tool for our customers. This handbook would amplify the basic information contained in MSDS to provide additional information about telomers and suggestions for overall occupational exposure reduction measures for our customers" consideration. In developing such a product, we would focus on ways to make it user friendly and practical. This TRP handbook will be developed for customer review by August 2003. Continuation ofTRP Research Activites `The TRP has had a research program underway for two years, which has focused primarily on the 8-2 Telomer Alcohol. Many of these efforts wil be producing important results in 2003. In light of EPA's expressed interest in the potential formation of PFOA from telomer-based products, the TRP is reconsidering the priority of new work on the 8-2 Telomer Alcohol. The TRP intends to complete the majority of the projects that are already underway. 3 Mr. Stephen L. Johnson March 14, 2003 Page 7 Relative to someofourcurrent work efforts, we very clearly understand there is concer within the EPA that it has taken 00 long (0 clarify whether there is biodegradation of our pmartoedruicatls tthoatPcFoOuAl.d beMuucsehd oifn tthhies btiiomdeegisraadttartiibountasbtlued to ies .ouTr RefPfonrtoswtohadse velop a supp "C-labeled ly of this material. `wiWlel apnrtoivciipdaeteintfhoerqmuaatliiotny vaanlduasbilgeniefniocuangchetoofjtuhsetidfayttahwe etiombetaainndweiftfhortthisspe"nCt.-labeled material Appendix 2 describes the 8-2 Telomer Alcohol workstreams the TRP has completed to sdautbemiatstewedltloatshethUosSeEuPnAde'rswAadym.inTihsetrraetsiuvletsRfercoomrdth2e2c6om(pAlRe-t2e2d6)soturdwiielslcibtehesrubhmaivtetebdeeans soon as the final report is completed. Appendix 3 contains a list and schedule of the reports from the TRP work on the 8-2 Telomer Alcohol, including those reports that will be provided to EPA during the remainder of 2003. Final study reports from TRP-sponsored studies will be submitted 10 EPA as soon as they become available. `We believe the actions described in this letter representa responsive and responsible `commitment by the TRP member companies to help address EPA's expressed interest in the paostteanntgiiabllfeoarsPpFoOssAibelex,poisnucrleudfirngomspteeclifoimcert-ibmealsiendesp.rodFuocrtsc.onWveeniheanvcee,mwaedehatvheesseucmommamriitzmeednts these commitments and timelines in Appendices 4 and 5. `TheTRP members appreciate the opportunity to work with EPA on this important matter and agree that communicating the progress on our efforts and sharing of information is important. Accordingly, we will continue to communicate with EPA when important information arises. In closing, we would like to emphasize that the TRP is committed to the continued safe manufacture, processing and use of telomer chemistry. We look forward to working with EPA in the future to achieve these goals. Respectfully submitted, TRP Member Companies 7 MMra.rcShte1p4h,e2n0L0.3Johnson Page 80. signature: __A, Arr Name: MH. Okuwe Title: Presidect AGA Chemicals, Inc. Signature: Name: Title: Clariant GmbH Signature: Name: Title: Daikin America, Inc. Signature: Name: Title: E.L duPont de Nemour&s Company Signature: Name: Title: Clariant GmbH g EE---- RECEIVED 0T3P/R141242114043 119063:0A0T FIR CILRIIANT LEG.PAGE 2 (7P0R4INST3E1D P7A1G3E1 TO2)Sines az Mr. Stephen L. Johnson March 14, 2003 Page 8b Sigoatwe: Name: Title: `AGA Chemicals, Inc. signee: asahilisi fbi, SessineResbad Gung go Name: HanslodugBuaid Name: RewahasdTag~~ Title: M" gnTaln aChed osca alo Title: Tiucologaat Clariant GmbB. Clariant GmbH Signature: Name: 00 Title: ____ Daikin America, ne. `Signature: Name: Title: E.I. duPont de Nemours & Company 9 wk TOTAL PGE. 02 6 03/14/03 FRI 15:20 FAX 256 306 5508 DAIKIN AMERICA @ooz eis h March14,2003 -- i---- -- AGAChemicalInsc,. -- ee-- --e-- Name _ Name: Clariant GmbH Clarisnt GmbH roerTtL ee = Signature: ________ Nome: ___ : E.LduPontde Nem&oCuomr pansy REACERI.VE1D410230/1043 211441554 1903 AT WRIGNIL Mr. Stephen L. Johnson March 14,2003 Page8d Signature: Name: Title: AGAChemicals, Inc. PAGE 2 (PRINTED Pace 2) 1 Signature: Name: Title: Clariant GmbH Signature: Name: Title: Clariant GmbH Signature: Name: Tite: Daikin America, Ine. Signature: Name: : oi Title: _ Tnoiiion Jofler EL duPont de Nemours & Company 21082 r.020002 0 Mr. Stephen L. Johnson March 14, 2003 Page 9 APPENDIX 1 ELL duPont de Nemours Company (DuPont) Telomer Manufacturing Facility Commitment DuPont manufactures telomers in the United States at the following sites: Chambers Works in Deepwater, New Jersey Washington Works in Parkersburg, West Virginia DuPont commits to the following with respect to manufacturing operations at these sites: 1) Developsite specific plans to assess levels of PFOA in air and water from manufacturing operations around each site; development of plans will begin not later than 30 days after the date of ths letter. 2) Conduct site-specificairdispersion modeling for applicable manufacturing operations, usingthe EPA approved Industrial Source Complex Short Term 3 (ISCSTS) model, as daensdcraissbeesdsitnhEePrAes'usltGsuuisdienlginteheoanirAisrcrQeueanliintgylMevoedleslesst(a4b0liCs.hFedR.inPWaretst51V,iArgpipneina.dix W), 3) Conduct ground and surface water analyses at each site, and assess the results using the water screening levels established in West Virginia. 4) Use the West Virginia screening levels to determine what additional actions, if any, may need to be taken, after reviewing the information with EPA. Six months after this Letter is submitted, reports will be submitted for each site on progress made with respect to environmental assessments. In addition to the environmental assessment commitments made above, DuPont will, by April 1, 2003, provide EPA with applicable existing industrial hygiene air monitoring data for PFOA from DuPont operations at Chambers Works. Also by April 1, 2003, the DuPont telomers. business will provide EPA with summary data on existing employee blood monitoring results (taking steps to preserve confidentiality) from telomer manufacturing operations and PFOA recycle operations at Chambers Works. =r MMra.rcShte1p4h,e2n0L0.3Johnson Page 10 APPENDI2X Summary of TRP Research Activities on 8-2 Telomer Alcohol T ESRer T 7S FPa)nTEPwP P1SEPam 8-2 Telomer Alcohol Studies ** Work Complete Work Underway buoabpctirveoniDo50seReayrcogeoFGnainvnggeorrtswTiottissouoeyysoncom e|||tcccooommmpptplyoeenn|J ||T1T N1}LT L T1L T |1 1 [cE erneaE rreoveErE envoiyonw~ee~s e=ar cohmne||| J ll|| ffae rormionssoesmypion: ra~eai~ snes fasten-Desorpton:StSeman &Sage 14c1 [socommpee ||1T1T1T1 Ti [progres || 1111 TTT Jy proFovamnreesseBmoLmaanadsna pioepenn; em [| weegeeen|| | [1]11 |[||| fimvoas-sRhaamgrecTorarnsdpoarit nProperdtiieseAPrTrWataer) Ar |[carwieso |||r ||e 1}g|w|s||sLJT]| pfpoezessamrmsarcnr:orneo aem:maamscnteioonmo--wmas------T[Tw[oceonovioonw||| ||oT||Tn ||I S JT T ffie PEavsooninvget1m0ym) fron tomeaoe [emoonn||||||| || TT| [emo ||||| JT fone sro gre rom Tore | J | (mErSioluosrptwoonwsMpaoino onos Woops |"compo|JRTI TT 1 | eee| fPoHAtRoMApCOrKiIoNErTICS (requires. Study Materia) cami] [1 beinoeEdOenveteepmnont iuerpttasneng L| coomien 1 | 1 1 1 TT J TT nomic yntet nvlpment r Cononstmioy n a) | comple | rT PfPs rroasstptsrsC"outemssoanneatry areenstoarucumnensn rater nors a |"cccooommmppp" oeosnn ||| ||| ||||MWW1T11[ 1[|1 1|| fstc SsoyynnmeihaabnsonrmpheagnrsSsttooernneorssSiysmST Eo SLE"ccoommppeonE||F|S| || |S| lJ|s| iWo[ rN 3 G|| |ET| io SUR 3 cont oe reper compro. 13 Mr. Stephen L. Johnson March 14, 2003 Page 11 APPENDIX 3 TR Final Report Schedule (8-2 Telomer Alcohol Studies) The Telomer Research Program (TRP) plans to submit final study reports to the US EPA, according to the schedule below. TRP will be keep EPA apprised of any modifications to the reporting schedule. [Note: Most of the TRP studies listed below were focused on 8-2 Telomer `Alcohol (CsFi7CH2CH;OH; CAS #678-39-7), a primary fluorotelomer intermediate. January 2003 (submitted) ~ Acute Oral Toxicity - Fixed Dose Method ~ In vivo Rat Micronucleus Assay ~ Salmonella-E.coli/Mammalian-Microsome Reverse Mutation Assay March 2003 Submitted Acute Aquatic Toxicity Tests: Fish (Zebrafish), Daphnia magna, Algae (Scenedesmus subspicatus) Limit Test with the Saturated Solution Limit Test with the Water Accommodated Fraction (WAF) ~ Microbial Respiration Inhibition Test with Activated Sludge Forthcoming ~ Physical-Chemical Properties of 8-2 Telomer Alcohol: Ultraviolet / Visible Absorption `Spectrum, Vapor Pressure, Water Solubility and Sorption Properties ~ Hydrolytic Stability of 8-2 Telomer Alcohol as a Function of pH ~ Atmospheric Degradation of the Fluorinated Alcohol, CyFirCH;CH;,OH ~ Temestrial Toxicity Studies: Earthworm, Nematode, Plants ~ Repeated Dose Oral Toxicity Gavage Range Finding Study in Rats ~ Subchronic Toxicity 90-day Oral Gavage Study in Rats ~ Bioconcentration in Carp [Note: This study was conducted for Japan METI and provided to the TRP. TRP did not fund the study directly but arranged for the translation into English.] ~ University of Toronto Year I Progress Report on Fluorotelomer Alcohols May / June 2003 ~ --AerwoitbhictrRaenasdfoyrmBaitoidoengrpardoadtuicotnsoafnd'Cm-aLsasbeblaleadn8c-e2 Telomer Alcohol (Modified OECD 301D) ~ Chronic Toxicity Study (21-day Daphnia) Future Submissions in 2003 (studies not yet underway) ~ Adsorption /Desorption of 8-2 Telomer Alcohol using a Batch Equilibrium Method ~ Qtr 3/ 2003 ~ Long-Range Transport Properties (Air/ Water) ~Qir 4/2003 14 Mr. Stephen L. Johnson March 14, 2003 Page 12 APPENDIX 4 TRP Commitment Summary In this Letter `commitment aonfdInatgernetetsottohperUovSidEePAE,PAthewiTtehldomeor cResuea/mrscuhebPmnriosgstriaosnms(oTnRPs)peocuitfliicnpelsasnisx areas and of activities to follow through on these items. The commitment items and dates are summarized below. 1. Product and Article Analysis Note: The products 10 be tested are those that the respective TRP member companies manufacture as actual itemsof commerce. The treated articles to be tested are actual carpet, textile, and paper substrates treated under representative mill conditions with the subject telomer-based polymeric products. ~ Description of scope and rationale for analyzing for PFOA in telomer-based polymeric products and telomer-treated articles. This study will cover representative polymeric products in commerce and the major end-use applications (carpet, textiles, and paper). Complete in March 2003. ~ Ipnrfoodrumcatttioonbefrteosmteidndiinvtihdiusalstcuodmyp(aCniAeSsnuunmdbeerr,CBcIheambiocuatlenaachmeteolrosmterru-cbtuarsaeldrpeoplryesmeenrtiac- tion if no CAS number, product, 2002 use and volume) -- to EPA by March 24, 2003. ~ Descriptionofother telomer-based products (including non-polymeric products) and applications in including CAS the United States not included number, chemical name or str in uct the ural Product and Article representation if no Analysis, CAS numb er , product and 2002 use and volume in commerce ~ to be provided by individual companies under CBI by May 2003. ~ Submit draft study plans for Product and Article Analysis and Sampling Guidance to EPA for review and comment -- completed on February 14, 2003. ~ Conduct analytical and sample method developmen--t by March / April 2003; conduct product and article analysis -- by May / June 2003. ~ Submit final report from screening study on Product and Article Analysi--s by June / July 2003. 2. Analysisof "Aged" Produancdt"Isn Use"Articles Note: For these analyses, "aged" means the storage and distribution ofproducts. "In-use" means the distribution and useof the treated articles. ~ Develop plan for conducting PFOA "aging" and "in use" analytical studies in initial end- use segments of carpet, textiles, and pape--r by April 2003. Address specific issues such exposure. as residual monomers, leaching, degradation, "walk off," volatilization, and light ~ Develop appropriate study protocols, analytical methods and appropriate test conditions to conduct these tests during Qtr 2 / 2003. ~ Conduct "aging" and "in use" analyses of the specific products and treated articles (carpet, textiles, paper) in the TRP-sponsored work under Item I above, once protocols and methods are available -- expected to be completed by Qtr 3 / 2003. Ig Mr. Stephen L. Johnson March 14, 2003 Page 13 3. Characterizing Potential ReleaseofPFOAfrom Telomer-Based Product Manufacture ~ Prepare general description of the process chemistry employed in telomer manufacturing and processing operations ~by end of March 2003. ~ Provide the locationofeach US TRP member telomer manufacturing and processing facility by March 24, 2003. ~ Describe specific telomer manufacturing process chemistry by member companies and information about potential releases of PFOA and exposure routes from these processes (US operations) ~by end of April 2003. ~ Develop action plans (by TRP member companies)to investigate the potential for PFOA release and exposure ~ by end of May 2003, 4. Characterizing Potential ReleaseofPFOAfrom Telomer-TreatedArticle Manufacture -- Develop estimates of potential release of PFOA related to manufacture of the primary article types (carpet, textiles and paper--) by June /July 2003. The release scenarios to be developed will cover potential occupational and environmental exposure related to the potential release of PFOA from article manufacture. ~ Provide EPA with results of release estimations of PFOA ~ by August/ September 2003. ~ Develop and demonstrate required sampling and analytical methods for PFOA determination in the mill simulations ~ in Qir 3 / 2003. ~ Conduct mill simulations of the potential releases of PFOA from telomer-treated article `manufacture to quantify the potential occupational and environmental exposure related to PFOA from article manufacture ~ begin during Qtr 3 / 2003 5. Biodegradation Analysis ~ Develop study approach, protocols and rationale for conducting biodegradation analyses of telomer-based polymeric products used in the Product and Article Analysis (Item | above) -- provide to EPA by April 2003 for review and comment. ~ Conduct biodegradation studies for potential generation of PFOA from polymeric products used in the Product and Article Analysi~s during Qtr 2-3 / 2003. ~ Submit results of polymer biodegradation analyses as they become available ~ expected to begin in July 2003. 6. Analysis ofIncineration ~ Compile information on telomer-based polymeric products and uses to understand the ultimate fate and disposal routes (landfill versus incineration) for telomer-treated articles in the United States -- provide to EPA by July 2003 ~ Review information on types of incineration tests that may be applicable and provide this information to EPA by end ofQtr 2/2003. 1e Mr. Stephen L. Johnson March 14, 2003 Page 14 Related Activities Information Exchange Listingofdocuments in the TRP database -- submit list to EPA by March 24, 2003. The documents will follow as soon astheycan be compiled, but no later than April 15, 2003. `The documentsare TRP and non-TRP reports on physical-chemical properties, toxicology, pharmacokinetics, and environmental fate and effects. ~ TRP will provide new documents, other materials, and final study reports to EPA as soon they become available. Individual companies will also submit documents, information, and final study reports to EPA related to their own studies on products sold in the US. market, as soon as they become available. ~ TRP will continue to provide periodic briefings to EPA staff to summarize current results from these telomer-related studies. These briefings are expected tooccur at least monthly in 2003. TRP will provide EPA advance notice for upcoming studies and report timing. Product Stewardshipfor Customers ~ TRP member companies will have additional product stewardship programs in place by July 2003 developed with reference to the Responsible Care guidelines outlined in the 'SOCMA Management Practices / Product Stewardship Code. Each company will provide documented evidence for their respective programs -- by July 2003. ~ Develop TRP Safe Handling and Use Handbook -- for customer review by August 2003. Continuation of TRPResearch Activities ~ Proceed with studies on 8-2 Telomer Alcohol in areas of physical-chemical properties, toxicity, pharmacokinetics, and environmental fate and effects (see Appendix 2). ~ Describe the method development and preliminary biodegradation studies conducted on 8-2 Telomer Alcohol (types of studies and rationale) ~ by March 2003. ~ Submit results from biodegradation analysoifs 8-2 Telomer Alcohol with both cold and "C-labeled material -- by March 21, 2003 (DuPont preliminary screening cold study) and June / July 2003 (TRP "C-labeled study). Submit final study reports from all TRP-sponsored studies to EPA as soon as they become available. ~ A schedule of TRP final report submissions for the 8-2 Telomer Alcohol studies is provided in the LOT Appendix 3. An updated list will be provided to EPA monthly in 2003. 17 Mr. Stephen L. Johnson March 14, 2003 Page 15 APPENDIX 5 RP Commitment Summary (Chronological Order) March 2003 1. Pinrotdeluocmtera-nbdasAerdtipcolleymAnearliycspirso:duDcetsscarinpdtitoenloomfers-ctorpeeataenddcorantsiuonmaelre afrotricalneas.lyzTihnigs fionirtiPalFOA saptpuldiyccatoivoenrss (rceaprrpeeste,ntteaxttiivleesp, oplaypmere)r.icDprraofdtuscttusdyinpcloanmsmewerrcee parnodvitdheedmatojoErPeAndi-nuFseebruary 2003 for review. 2. Parcohdutceltoamnerd-bAarsteicdlpeoAlnyamleyrsiics:proIdnufcotrmtaotiboentefsrtoemd iinndtihviisdsutauldcyo(mCpAanSiensumubnedre,rcChBeImiacbaolut name or structural commerce). representation if no CAS number, product, 2002 use and volume in 3. CPrhoavriadcetegreinezrealPodteesnctriiapltiRoenloefasteheopfrPocFeOssAcfhermoimstTreyleommpelro-yBeadseidn tPerloodmuecrtmaMnaunfuafcatcutruirnge:and processing operations. Provide Location of each US TRP member telomer manufacturing and processing facility. 4. Biodegradation Studies (8-2 Telomer Alcohol): Description of the method development and and preliminary rationale). biodegradation studies conducted on 8-2 Telomer Alcohol (types of studies 5. Biodegradation Studies (8-2 Telomer Alcohol): Deliver results from biodegradation analysis of 8-2 Telomer Alcohol with cold material (DuPont preliminary screening study). 6. Information Exchange: Submit list of documents, other materials and final study reports contained in the TRP database; documents to follow when compiled (Apri). April 2003 1. Productand Article Analysis: Conduct analytical and sample method development 2. Analysis of "Aged" Products and "In Use" Articles: Submit plan for conducting PFOA "aging" and "in use" analytical studies in initial end-use segments of carpet, textiles, and paper. Address specific issues such as residual monomers, leaching, degradation, "walk off," volatilization, and light exposure. 3. Characterize Potential Release of PFOA from Telomer-Based Product Manufacture: Description of specific telomer manufacturing process chemistry by member companies and information operations). about potential releases of PFOA and exposure routes from these processes (US 4. Biodegradation Analysis (Polymeric Products): Provide for EPA review the study approach, protocols and rationale for biodegradation analysis of polymeric products in the Product and Article Analysis (Item 1). 5. Information Exchange: Provide copies of documents and other materials from the TRP database. 8 Mr. Stephen L. Johnson March 14, 2003 Page 16 May 2003 1. pPorloydmuecrticanprdodAurcttisc)leaAnndaalpypsliisc:atiDoensscriinptthieonUnoiftoetdheSrtatteelsonmoetr-ibnacsleuddepdroidnutchtesP(riondculucdtiangndnonACrAtiSclneuAmnbaelry,sipsr,odiuncctl,ud2i0n0g2CuAsSe annudmbveorl,ucmheeminiccaolmnmaermceeor--sttorubcetuprraolvriedperdesbeyntiantdiiovnidiufanlo companies under CBI. 2. Product and Article Analysis: Conduct product and article analyses and compile results. 3. TChRaPramcetmerbiezrecPoomtpenatniiaelsRweilleladseeveolfoPpFacOtAionfrpolamnsTetoloimnevers-tBigaasteedthPeropodtuecnttiaMlanfourfaPcFtOuAre: release and exposure. June 2003 1. Analysis of "Aged" Products and "In Use" Articles: Develop appropriate analytical methods and study protocols to conduct these analyses. TRP will needtodefine appropriate "aging" and "in use" conditions to conduct these tess. 2. CDheavrealcotpeersitziemaPtoetsenotfipaolteRnetlieaalsreeloefasPeFoOfAPFfOroAmrTelealtoedmetro-tThreemaatneudfaAcrttuirceleofMatnhruefeapcrtiumraer:y article types (carpet, textiles and paper). The release scenarios to be developed will cover occupational and environmental exposure related to potential release of PFOA from article manufacture. 3. Analysis of Incineration: Review information applicable and provide a summary to EPA. on types of incineration tests that may be July 2003 1. Product and Article Analysis: Article Analysis Submit final report from screening study on Product and 2. DCehvarealcotpearnidzedePmootennsttiraalteRreequlireeodfasPaFmspOleAingfranodmaTneallyotmiecral-Tmreetahtoedds AfrotriPclFeOMAanduetfearcmtiunratei:on in the mill simulations. 3. Biodegradation Studies (8-2 Telomer Alcohol): Deliver results from biodegradation 4. aBniaoldyesgisraodfa8t-i2oTneAlnoamleyrsiAslc(oPhoollymweirtihc"PCr-oldaubcetlse)d:mCaotenrdiuaclt(bTiRoPdesgtruaddya)t.ion analysis for PFOA of polymeric products used in the Product and Article Analysis under Item 1. 5. Analysis of Incineration: Compile information on telomer-based polymeric products and uses 10 understand the ultimate fate and disposal telomer-treated articles in the United States routes (landfill versus incineration) for 6. Product Stewardship for Customers: TRP member companies will have additional pgurioddeulcitnessteowuatrldisnheidpinprtohegrSaOmsCiMn AplMacaendaegveemleonptedPwritah rceft/erPierncocdeeutcsotfSotreRweasrpdosnhsiipblCeodCea.re August 2003 1. Characterize Potential Release of PFOA from Telomer-Treated Article Manufacture: `Submit results of release estimations of PFOA from article manufacture. 19 Mr. Stephen L. Johnson March 14, 2003 Page 17 2. Biodegradation Analysis (Polymeric Products): Submit results of biodegradation analyses for PFOA in polymeric products 3. Product Stewardship for Customers: Provide TRP Safe Handling and Use Handbook to customers for review. September 2003 1. Analysisof "Aged" Products and "In Use" Articles: Conduct "aging" and "in use" analyses of the specific products and treated articles (carpet, textiles, paper) in TRPsponsored work under tem 1, once methods and protocols are available study conducted. 2. Characterize Potential ReleaseofPFOA from Telomer-Treated Article Manufacture: Initiate mill simulations of the potential release of PFOA from telomer-treated article manufacture to estimate the potential occupational and environmental exposure of PFOA from article manufacture. Continue mill simulations into Q4u/20r03. 20